June 22, 2025Boston Congress of Public Health Review (BCPHR Formerly HPHR)Open Access

The Price of Survival: Ethical Failures and Pharmaceutical Profit in the U.S. Drug Market

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis shows access barriers impact affordability in low-income populations, suggesting reforms could enhance equity.

Exorbitant pricing of insulin and hepatitis C treatments burdens vulnerable communities, impacting access and affordability.
The analysis demonstrates how corporate strategy and regulatory gaps contribute to market exclusion and health disparities.
Applying frameworks of consequentialism and distributive justice reveals engineered outcomes of preventable harm in drug pricing.
Proposed reforms include price negotiation and patent law overhaul to realign pharmaceutical innovation with public welfare.

Jonathan Lee (2025) studied this question.

View Full Paper

Ask AI

Bookmark